HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the HeartFlow Planner, a non-invasive, real-time virtual modeling tool for coronary artery disease (CAD)...
FFR Technologies
This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.
-
-
One of the big trends in cardiac computed tomography (CT) imaging has been the introduction of noninvasive ...
-
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 annual meeting March 16-18,...
-
Why CT angiography cannot replace invasive angiography
Technology | CT Angiography (CTA) | September 12, 2019
September 12, 2019 — HeartFlow Inc. has obtained clearance from the U.S. Food and Drug Administration (FDA) for the...
In June 2019, Medis received clearance from the U.S. Food and Drug Administration for its QAngio XA 3D technology (QFR). The FFR-angio technology can show the FFR readings in a 3-D image and overlaid on a fluoro image.
Feature | FFR Technologies | August 05, 2019 | Dave Fornell and Greg Freiherr
New technologies have been developed that may replace the traditional pressure wires and adenosine to assess the...
An example of FFR-CT imaging from Beaumont Hospital in Royal Oak, Mich. The left image shows a 3D generated image of the coronary tree from a CT scan evaluated with computational fluid dynamics to determine the FFR numbers. It shows a severe restriction of the left main artery which requires a stent to revacularize. The image on the right is a comparison with the invasive angiogram from the cath lab prior to stenting.
Feature | CT Angiography (CTA) | July 24, 2019 | Greg Freiherr
One of the big trends in cardiac computed tomography (CT) imaging has been the introduction of noninvasive ...
News | Cath Lab | June 19, 2019
June 19, 2019 — Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic...
News | FFR Technologies | June 17, 2019
June 17, 2019 – A prospective, multicenter, multinational study examines how...
Technology | Angiography | June 04, 2019
June 4, 2019 — Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration...
News | CT Angiography (CTA) | May 28, 2019
May 28, 2019 — New data demonstrated that use of the investigational HeartFlow Planner, a real-time, non-invasive...
Technology | Intravascular Imaging | May 20, 2019
May 20, 2019 — Philips announced the launch of the new IntraSight...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.
Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the...
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr
Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of ...
The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.
Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the...
News | FFR Technologies | March 19, 2019
March 19, 2019 — Late-breaking results confirm the HeartFlow FFRct (...
Abbott's Resting Full-cycle Ratio (RFR) intravascular diagnostic test is a newer type of fractional flow reserve (FFR) physiologic assessment. RFR is used to help identify significant narrowings of coronary arteries to determine the need for a stent or if a patient can be treated medically.
Technology | FFR Technologies | March 06, 2019
March 5, 2019 – The U.S. Food and Drug Administration (FDA) cleared Abbott's Resting Full-cycle Ratio (RFR)...
